Recent Publications

Bitte geben Sie einen Suchbegriff ein.

Donner L, Gremer L, Ziehm T, Gertzen CGW, Gohlke H, Willbold D, Elvers M.

Relevance of N-terminal residues for amyloid-β binding to platelet integrin αIIbβ3, integrin outside-in signaling and amyloid-β fibril formation.

Cell Signal. 2018 Oct;50:121-130. doi: 10.1016/j.cellsig.2018.06.015. Epub 2018 Jun 30. PubMed ID: 29964150

 

Further Information:

undefinedPubMed

undefinedDieter Willbold


Abdel-Hafiz L, Müller-Schiffmann A, Korth C, Fazari B, Chao OY, Nikolaus S, Schäble S, Herring A, Keyvani K, Lamounier-Zepter V, Huston JP, de Souza Silva MA.

Aβ dimers induce behavioral and neurochemical deficits of relevance to early Alzheimer's disease.

Neurobiol Aging. 2018 Sep;69:1-9. doi: 10.1016/j.neurobiolaging.2018.04.005. Epub 2018 Apr 17. PubMed ID: 29803148

 

Further Information:

undefinedPubMed

undefinedCarsten Korth

undefinedJoseph P. Huston

undefinedMaria Angelica de Souza Silva


Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Lancet Neurol. 2018 Aug;17(8):689-698. doi: 10.1016/S1474-4422(18)30202-3. Epub 2018 Jul 9. PubMed ID: 30001923

 

Further Information:

undefinedPubMed

undefinedHans-Peter Hartung


Sievers P, Stichel D, Schrimpf D, Sahm F, Koelsche C, Reuss DE, Wefers AK, Reinhardt A, Huang K, Ebrahimi A, Hou Y, Pajtler KW, Pfister SM, Hasselblatt M, Stummer W, Schick U, Hartmann C, Hagel C, Staszewski O, Reifenberger G, Beschorner R, Coras R, Keyvani K, Kohlhof P, Diomedi-Camassei F, Herold-Mende C, Giangaspero F, Rushing E, Giannini C, Korshunov A, Jones DTW, von Deimling A.

FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.

Acta Neuropathol. 2018 Aug;136(2):293-302. doi: 10.1007/s00401-018-1882-3. Epub 2018 Jul 5. PubMed ID: 29978331

 

Further Information:

undefinedPubMed

undefinedGuido Reifenberger


Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Japeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U.

DNA methylation-based reclassification of olfactory neuroblastoma.

Acta Neuropathol. 2018 Aug;136(2):255-271. doi: 10.1007/s00401-018-1854-7. Epub 2018 May 5. PubMed ID: 29730775

 

Further Information:

undefinedPubMed

undefinedGuido Reifenberger


Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, Thomale UW, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Mueller W, Tuffaha MSA, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Monoranu CM, Kessler AF, Loehr M, Buslei R, Deckert M, Mawrin , Kohlhof P, Hewer E, Olar A, Rodriguez FJ, Giannini C, NageswaraRao AA, Tabori U, Nunes NM, Weller M, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Jones DTW, von Deimling A, Capper D.

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.

Acta Neuropathol. 2018 Aug;136(2):273-291. doi: 10.1007/s00401-018-1837-8. Epub 2018 Mar 21. PubMed ID: 29564591

 

Further Information:

undefinedPubMed

undefinedGuido Reifenberger


Elmenhorst EM, Elmenhorst D, Benderoth S, Kroll T, Bauer A, Aeschbach D.

Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A1 receptors.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):8009-8014. doi: 10.1073/pnas.1803770115. Epub 2018 Jul 16. PubMed ID: 30012607

 

Further Information:

undefinedPubMed

undefinedAndreas Bauer


Cohen JA, Comi G, Arnold DL, Bar-Or A, Selmaj KW, Steinman L, Havrdová EK, Cree BA, Montalbán X, Hartung HP, Huang V, Frohna P, Skolnick BE, Kappos L; RADIANCE Trial Investigators.

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.

Mult Scler. 2018 Jul 25:1352458518789884. doi: 10.1177/1352458518789884. [Epub ahead of print] PubMed ID: 30043658

 

Further Information:

undefinedPubMed

undefinedHans-Peter Hartung


Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, Löffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, Reifenberger G, Pfister SM, Tonn JC, Weller M; German Glioma Network.

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

Neuro Oncol. 2018 Jul 24. doi: 10.1093/neuonc/noy118. [Epub ahead of print] PubMed ID: 30053291

 

Further Information:

undefinedPubMed

undefinedGuido Reifenberger


Poeppl TB, Donges MR, Mokros A, Rupprecht R, Fox PT, Laird AR, Bzdok D, Langguth B, Eickhoff SB.

A view behind the mask of sanity: meta-analysis of aberrant brain activity in psychopaths.

Mol Psychiatry. 2018 Jul 23. doi: 10.1038/s41380-018-0122-5. [Epub ahead of print] PubMed ID: 30038232

 

Further Information:

undefinedPubMed

undefinedSimon B. Eickhoff


Treffer 1 bis 10 von 70

Verantwortlich für den Inhalt: E-Mail sendenNeuroscience Network Düsseldorf